Beta · prototype— This site is under construction: rankings, texts and features change every week.

Anocca

Active#27 in Sweden

TCR-T cell therapy

Founded2014
HQSödertälje
RaisedUndisclosed total
Last roundEquity round · Aug 2025
Country of originSwedenListed in the Sweden ranking
Where would you invest?SwedenJurisdiction as cited by the ranking

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Sweden · all sectorsTop 50#27Edition 0 – beta · October 202625 Oct 2026
Rank historyOct 2026 · #27First edition: no movements yet.

Estimated valuation

AI · Sweden ranking
≈ USD 240MUSD 120–480M · Hundreds of M$ Low confidence
Anchor
Last known equity round: Equity round · USD 46M · Aug 2025
AI adjustment
None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Funding history

Undisclosed total raised in total
DateRoundAmountTypeInvestors
Aug 2025Equity roundUSD 46M (SEK 440M)EquityMellby Gård, AMF

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Anocca as a PDF, on one of three angles only:

ValuationWhat is Anocca worth?
Versus competitorsIs #27 the right rank?
Who should acquire itStrategic buyers, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in Sweden

Full Sweden ranking →

Investors in Anocca: Mellby Gård · AMF

Last updated: Oct 2026Report an error

Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.